Professor Afzal Hussain Featured at NP Discovery 2027
Apigenin-Mediated MARK4 Inhibition and Alzheimer's Disease Research
Professor Afzal Hussain, Professor of Pharmacognosy at King Saud University, Saudi Arabia, will present his research at NP Discovery 2027 – International Congress on Natural Products, Botanicals & Herbal Drug Discovery.
ðŽ Presentation Title
Apigenin-mediated MARK4 inhibition: A novel approach in advancing Alzheimer's disease therapeutics
Apigenin is a naturally occurring flavonoid widely distributed in fruits, vegetables, and medicinal plants. Its biological properties, including reported neuroprotective activity, have generated interest in its potential applications in neurodegenerative disease research.
Professor Hussain's work examines Microtubule Affinity-Regulating Kinase 4 (MARK4) as a possible molecular target of apigenin. The study combines molecular modeling, biochemical evaluation, and fluorescence-based binding studies to investigate apigenin–MARK4 interactions.
The research reports inhibitory activity of apigenin against purified recombinant MARK4, with an IC₅₀ of 2.39 ΞM. The findings provide a basis for further investigation into the role of apigenin–MARK4 signaling in Alzheimer's disease and other disorders associated with kinase dysregulation.
ðĻðŽ Meet Professor Afzal Hussain
Professor Afzal Hussain is a Professor of Pharmacognosy at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
His research interests include:
Natural Products | Medicinal Plants | Bioactive Compounds | Pharmacognosy | Drug Delivery | Therapeutic Molecules
He holds a Ph.D. in Chemistry from Jamia Millia Islamia, New Delhi, and is a Member of the Royal Society of Chemistry. With more than 15 years of academic and research experience, he has authored 220+ scientific publications, with 7,000+ citations and an h-index of 49.
ðą From Natural Compounds to Therapeutic Research
The presentation demonstrates the potential of combining natural-product-derived molecules with modern molecular and pharmacological approaches to investigate therapeutic targets.
This research aligns with the broader scientific scope of NP Discovery 2027, where natural products are explored through contemporary approaches in drug discovery, pharmacology, biotechnology, molecular science, and therapeutic development.
ð NP Discovery 2027
The International Congress on Natural Products, Botanicals & Herbal Drug Discovery will be held on March 22–24, 2027, in Singapore and Online.
Theme: Rooted in Nature, Driven by Discovery
The hybrid congress will bring together global researchers and professionals to discuss advances in natural product chemistry, plant-derived therapeutics, herbal drug development, phytopharmaceuticals, nutraceuticals, bioactive compounds, emerging technologies, clinical validation, and commercialization.
ð Event Information
ð
March 22–24, 2027
ð Singapore & Online
ð 15+ CPD Credits
ðĨ 20% Team Discount for 3+ Colleagues
ð Useful Links
Speaker Profile:
https://naturalproductscongress.com/speaker/afzal-hussain
Website:
https://naturalproductscongress.com/
Registration:
https://naturalproductscongress.com/register
ðŽ Discover the Latest in Natural Product Research
Connect with researchers, scientists, academics, healthcare professionals, and industry experts at NP Discovery 2027 and explore new directions in natural products and herbal drug discovery.
Rooted in Nature, Driven by Discovery.
#NPDiscovery2027 #AfzalHussain #Apigenin #NaturalProducts #HerbalDrugDiscovery #DrugDiscovery #Pharmacognosy #Phytochemistry #AlzheimersResearch #BioactiveCompounds #ScientificConference #Singapore
No comments:
Post a Comment